| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 09/11/2001 | US6288278 Benzene derived amino alcohols as drugs |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288105 Antithrombotic agents |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288085 Piperidine derivatives for treating psychoses |
| 09/11/2001 | US6287818 Conjugating, in single reaction mixture, retinoic acid with homocysteine thiolactone to form n-homocysteine thiolactonyl retinamide, then mixing with 5'-deoxyadenosine cobalamin; high purity and yield; anticancer agents with reduced toxicity |
| 09/08/2001 | CA2300502A1 Process for the preparation of a polyaromatic compound |
| 09/07/2001 | WO2001064814A1 Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds |
| 09/07/2001 | WO2001064683A1 Processes for the production of thienopyrimidine derivatives |
| 09/07/2001 | WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents |
| 09/07/2001 | WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 09/07/2001 | WO2001064642A2 Benzamides and related inhibitors of factor xa |
| 09/07/2001 | WO2001055111A8 Biaryl compounds, their preparation and their use in therapy |
| 09/07/2001 | WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | CA2401379A1 Processes for the production of thienopyrimidine derivatives |
| 09/06/2001 | US20010020024 Opioid analgesics |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010019783 Organic electroluminescent device |
| 09/05/2001 | EP1129087A1 Process for racemization |
| 09/05/2001 | EP0873304B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0777646B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/04/2001 | USRE37355 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 09/04/2001 | US6284796 Naphthamidine compounds |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | US6284756 Anticoagulant |
| 09/04/2001 | CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062718A1 Benzamide derivative and use thereof |
| 08/30/2001 | WO2001062715A1 Novel cd23 inhibitors |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062708A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001016131A3 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 08/30/2001 | US20010018525 Modulating blood glucose concentration |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018405 For use as plant protecting fungicides, by reacting an orthocarbonate with a compound such as a 2-(1,1-dipropoxymethyleneamino)thiophene-3-carboxylic acid propyl amide and cyclizing the resulting intermediate |
| 08/30/2001 | DE10102631A1 Thiophencarbonsäureester und flüssigkristallines Medium Thiophencarbonsäureester and liquid crystalline medium |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2397234A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | EP0738260B1 Pesticides |
| 08/29/2001 | CN1310717A Process for the dehalogenation of thiochroman and dihydrobenzothiophene derivatives |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | US20010016595 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/22/2001 | EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1124832A1 Oxime derivatives and the use thereof as latent acids |
| 08/22/2001 | EP1124819A1 Method of lithiating five-membered heterocycles |
| 08/22/2001 | EP0830356B1 PROCESS FOR THE SYNTHESIS OF BENZO(b)THIOPHENES |
| 08/22/2001 | CN1309635A Benzocycloheptenes, method for production thereof, pharmaceutical preparations contg. these compounds, and their use for producing medicaments |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309631A Aminomethylcarboxylic acid derivs |
| 08/22/2001 | CN1309126A S-(2H-thien-2-yl) methyl alkylxanthogenate |
| 08/21/2001 | US6277995 Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | US6277503 Containing a methylidene compound |
| 08/21/2001 | CA2000362C Methyl .alpha.-arylacrylates substituted by a heterocyclic radical and their use |
| 08/16/2001 | WO2001058890A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 08/16/2001 | WO2001007431A3 Benzothiophene derivatives |
| 08/16/2001 | WO2000063202A8 BENZO[b] THIOPHENE SULFONAMIDE-1, 1-DIOXIDE DERIVATIVES AND THEIR USE AS ANTINEOPLASTIC AGENTS |
| 08/16/2001 | WO2000041531A3 Serine protease inhibitors |
| 08/16/2001 | US20010014745 Process for the prepartion of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein |
| 08/16/2001 | US20010014683 Analgesics; side effect reduction |
| 08/16/2001 | EP1144373A3 Serine protease inhibitors |
| 08/16/2001 | EP1123933A1 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123291A1 Process for preparing 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles and novel intermediates utilized therein |
| 08/16/2001 | EP1123286A1 Sulfolane and process therefor |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | EP0885251B1 Substituted polythiophenes, processes for their preparation and their use |
| 08/16/2001 | EP0882033B1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308627A 11-Aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-aryl-benzo[b]anphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308626A Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308625A Naphtho [2,3-b] heteroar-4-yl derivatives |